Skip to main content
SpringerLink
Log in

Methods for volume assessment of prostate cancer

  • Urogenital
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

This paper presents current knowledge on the prognostic significance of prostate cancer volume, reviews the feasibility of state-of-the-art imaging techniques for its assessment, and briefly introduces future perspectives regarding technical developments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics. CA Cancer J Clinc 49:8–31, 1

    CAS  Google Scholar 

  2. Mettlin CJ, Murphy GP, Rosenthal DS, Menck HR (1999) The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the US. The American College of Surgeons Commissions on Cancer and the American Cancer Society. Cancer 83:1679–1684

    Article  Google Scholar 

  3. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC (2001) Long-term biochemical disease free survival and cancer specific survival following anatomic radical prostatectomy. Urol Clin North Am 28:555–565

    CAS  PubMed  Google Scholar 

  4. Humphrey PA, Frazier HA, Vollmer RT, Paulson DF (1993) Stratification of pathological features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels. Cancer 71:1821–1827

    CAS  PubMed  Google Scholar 

  5. Humphrey PA, Walter PJ (1993) Adenocarcinoma of the prostate. Part II. Tissue prognosticators. Am J Clin Pathol 100:256–269

    CAS  PubMed  Google Scholar 

  6. Epstein JI, Pizov G, Walsh PC (1993) Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 71:3582–3593

    CAS  PubMed  Google Scholar 

  7. Egevad L, Norberg M, Mattson S, Norlen BJ, Busch C (1998) Estimation of prostate cancer volume by multiple core biopsies before radical prostatectomy. Urology 52:653–658

    Article  CAS  PubMed  Google Scholar 

  8. McNeal JE (1992) Cancer volume and site of origin of adenocarcinoma of the prostate: relationship to local and distant spread. Hum Pathol 23:258–266

    CAS  PubMed  Google Scholar 

  9. Babaian RJ, Troncoso P, Steelhammer LC, Lloreta-Trull J, Ramirez EI (1995) Tumor volume and prostate specific antigen: implications for early detection and defining a window of curability. J Urol 154:1808–1812

    Article  CAS  PubMed  Google Scholar 

  10. Bostwick DG, Graham SD, Napalkov P, Abrahamsson PA, Sant’Agnese PA, Algaba F, Hoisaeter PA, Lee F, Littrup P, Mostofi FK, Denis L, Schroeder F, Murphy GP (1993) Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 41:403–411

    CAS  PubMed  Google Scholar 

  11. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM (1999) Biological determinants of cancer progression in men with prostate cancer. JAMA 281:1395–1400

    CAS  PubMed  Google Scholar 

  12. Salomon L, Levrel O, Anastasiadis AG, Irani J, de la Taille A, Saint F, Vordos D, Cicco A, Hoznek A, Chopin D, Abbou CC (2003) Prognostic significance of tumor volume after radical prostatectomy: a multivariant analysis of pathologic prognostic factors. Eur Urol 43:39–44

    Article  PubMed  Google Scholar 

  13. Epstein JI, Carmichael M, Partin AW, Walsh PC (1993) Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariant analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow up. J Urol 149:1478–1481

    CAS  PubMed  Google Scholar 

  14. Miller GJ (1989) Pathologic aspects of prostate cancer: prediction of malignant potential. Urology 34[Suppl 4]:5–9

  15. Miller GJ, Cygan JM (1994) Morphology of prostate cancer: the effect of multifocality on histological grade, tumor volume and capsule penetration. J Urol 152:1709–1713

    CAS  PubMed  Google Scholar 

  16. Epstein JI, Carmichael MJ, Partin AW, Walsh PC (1994) Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical importance. J Urol 151:1587–1592

    CAS  PubMed  Google Scholar 

  17. Hirano D, Werahera PN, Crawford ED, Lucia MS, DeAntoni EP, Miller GJ (1998) Morphological analysis and classification of latent prostate cancer using a 3-dimensional computer algorithm: analysis of tumor volume, grade, tumor doubling time and life-expectancy. J Urol 159:1265–1269

    Article  CAS  PubMed  Google Scholar 

  18. Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC (1990) Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 143:747–752

    CAS  PubMed  Google Scholar 

  19. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, Nadler RB (1995) Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274:1214–1220

    Article  CAS  PubMed  Google Scholar 

  20. Grossklaus DJ, Smith JA, Shappell SB, Coffey CS, Chang SS, Cookson MS (2002) The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA. Urol Oncol 7:195–198

    Article  CAS  PubMed  Google Scholar 

  21. Grossklaus DJ, Coffey CS, Shappell SB, Jack GS, Chang, SS, Cookson MS (2002) Percent of cancer in the biopsy set predicts pathological findings after prostatectomy. J Urol 167:2032–2036

    Article  PubMed  Google Scholar 

  22. Daneshgari F, Taylor GD, Miller GJ, Crawford ED (1995) Computer simulation of the probability of detecting low volume carcinoma of the prostate with six random systematic core biopsies. Urology 45:604–609

    Article  PubMed  Google Scholar 

  23. Loughlin M, Carlbom I, Busch C, Douglas T, Egevad L, Frimmel H, Norberg M, Sesterhenn I, Frogge JM (1998) Three-dimensional modeling of biopsy protocols for localized prostate cancer. Comput Med Imaging Graph 22:229–238

    Article  CAS  PubMed  Google Scholar 

  24. Egevad L, Frimmel H, Norberg M, Mattson S, Carlbom I, Bengtsson E, Busch C (1999) Three-dimensional computer reconstruction of prostate cancer from radical prostatectomy specimens: evaluation of the model by core biopsy simulation. Urology 53:192–198

    Article  CAS  PubMed  Google Scholar 

  25. Jager GJ, Ruijter ETG, van de Kaa, CA, de la Rosette JJMCH, Ooosterhof GON, Thornbury JR, Barentz JO (1996) Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. Am J Roentgenol 166:845–852

    CAS  Google Scholar 

  26. Ponchietti R, Di Loro F, Fanfani A, Amorosi A (1999) Estimation of prostate cancer volume by endorectal coil magnetic resonance imaging pathologic volume. Eur Urol 35:32–35

    Article  CAS  Google Scholar 

  27. Pirtskhalaishvili G, Hrebinko RL, Nelson JB (2001) The treatment of prostate cancer. An overview of current options. Cancer Pract 9:295–306

    Article  CAS  PubMed  Google Scholar 

  28. Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC (1989) Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol 141:341–345

    CAS  PubMed  Google Scholar 

  29. Hendrikx A, van Helvoort-van Dommelen C, van Dijk MA, Reintjes AG, Debruyne FM (1989) Ultrasonic determination of prostatic volume: a cadaver study. Urology 34:123–125

    CAS  PubMed  Google Scholar 

  30. Aarnink R, de la Rosette J, Debruyne F, Wijkstra H (1996) Formula-derived prostate volume determination. Eur Urol 29:399–402

    CAS  PubMed  Google Scholar 

  31. Aarnink R, Giesen R, de la Rosette J, Huynen A, Debruyne F, Wijkstra H (1995) Planimetric volumetry of the prostate: how accurate is it? Physiol Meas 16:141–150

    Article  CAS  PubMed  Google Scholar 

  32. Augustin H, Graefen M, Palisaar J, Blonski J, Erbersdobler A, Daghofer F, Huland H, Hammerer P (2003) Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for staging. J Clin Oncol 21:2860–2868

    Article  PubMed  Google Scholar 

  33. Shinohara K, Wheeler T, Scardino P (1989) The appearance of prostate cancer on transrectal ultrasonography. Correlation of imaging and pathological examinations. J Urol 142:76–82

    CAS  PubMed  Google Scholar 

  34. Terris M, McNeal J, Stamey T (1992) Estimation of prostate cancer volume by transrectal ultrasound imaging. J Urol 147:855–857

    CAS  PubMed  Google Scholar 

  35. Kojima M, Troncoso P, Babaian RJ (1995) Use of prostate-specific antigen and tumor volume in predicting needle biopsy grading error. Urology 45:807–812

    Article  CAS  PubMed  Google Scholar 

  36. Okihara K, Watanabe H (1994) Kinetic analysis of focal hypoechoic lesions in the prostate treated by castration. Prostate 24:252–256

    CAS  PubMed  Google Scholar 

  37. Watanabe H, Kojima M (1997) The role of prostatic planimetry using transrectal sonography in prostatic diseases. Semin Surg Oncol 13:425–430

    Article  CAS  PubMed  Google Scholar 

  38. Shigeno K, Igawa M, Shiina H, Wada H, Yoneda T (2000) The role of colour doppler ultrasonography in detecting prostate cancer. BJU Int 86:229–233

    Article  CAS  PubMed  Google Scholar 

  39. Halpern E, Frauscher F, Strup S, Nazarian L, O’Kane P, Gomella L (2002) Prostate: high-frequency Doppler US imaging for cancer detection. Radiology 225:71–77

    PubMed  Google Scholar 

  40. Bogers HA, Sedelaar JP, Beerlage HP, de la Rosette JJ, Debruyne FM, Wijkstra H, Aarnink RG (1999) Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 54:97–104

    Article  PubMed  Google Scholar 

  41. Pepe P, Patane D, Panella P, Aragona F (2003) Does the adjunct of ecographic contrast medium Levovist improve the detection rate of prostate cancer? Prostate Cancer Prostatic Dis 6:159–162

    Article  CAS  PubMed  Google Scholar 

  42. Bezzi JI, Kressel HY, Allen KS, Schiebler ML, Altman HG, Wein AJ, Pollack HM (1988) Prostrate carcinoma: staging with MR imaging at 1.5 T. Radiology 169:339–346

    CAS  PubMed  Google Scholar 

  43. Kahn T, Bürrig K, Schmitz-Drager B, Lewin JS, Furst G, Modder U (1989) Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation. Radiology 173:847–851

    CAS  PubMed  Google Scholar 

  44. McSherry SA, Levy F, Schiebler ML, Keefe B, Dent GA, Mohler JL (1991) Preoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer: comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging. J Urol 146:85–89

    CAS  PubMed  Google Scholar 

  45. Quint LE, van Erp JS, Bland PH, Mandell SH, del Buono EA, Grossman HB, Glazer GM, Gikas PW (1999) Carcinoma of the prostate: MR images obtained with body coils do not accurately reflect tumor volume. Am J Roentgenol 156:511–516

    Google Scholar 

  46. Outwater E, Schiebler ML, Tomaszewski JE, Schnall MD, Kressel HY (1992) Mucinous carcinomas involving the prostate: atypical findings at MR imaging. J Magn Reson Imaging 2:597–600

    CAS  PubMed  Google Scholar 

  47. Sommer FG, Hghiem HV, Herfkens R, McNeal JE, Low RN (1993) Determining the volume of prostatic carcinoma: value of MR imaging with an external array coil. Am J Roentgenol 161:81–86

    Google Scholar 

  48. Schnall MD, Lenkinski RE, Pollack HM, Imai Y, Kressel HY (1989) Prostate: MR imaging with an endorectal surface coil. Radiology 172:570–574

    CAS  PubMed  Google Scholar 

  49. Hricak H, White S, Vigneron D, Kurhanewicz J, Kosco A, Levin D, Weiss J, Narayan P, Carroll PR (1994) Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 193:703–709

    CAS  PubMed  Google Scholar 

  50. Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO (2002) Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12:2294–2302

    PubMed  Google Scholar 

  51. Jager GJ, Severens JL, Thornbury JR, de La Rosette JJ, Ruijs SH, Barentsz JO (2000) Prostate cancer staging: should MR imaging be used? A decision analytic approach. Radiology 215:445–451

    CAS  PubMed  Google Scholar 

  52. Harris RD, Schned AR, Heaney JA (1995) Staging of prostate cancer with endorectal MR imaging: lessons from a learning curve. Radiographics 15:813–829

    CAS  PubMed  Google Scholar 

  53. Padhani AR, MacVicar AD, Gapinski CJ, Dearnaley DP, Parker GJM, Suckling J, Leach MO, Husband JE (2001) Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology 218:365–374

    CAS  PubMed  Google Scholar 

  54. D’Amico AV, Chang E, Garnick M, Kantoff P, Jiroutek M, Tempany CM (1998) Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: a new predictor of tumor response to neoadjuvant androgen suppression therapy. Urology 51:287–292

    Article  CAS  PubMed  Google Scholar 

  55. White S, Hricak H, Forstner R, Kurhanewicz J, Vigneron DB, Zaloudek CJ, Weiss JM, Narayan P, Carroll PR (1995) Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 195:385–390

    CAS  PubMed  Google Scholar 

  56. Coakley FV, Kurhanewicz J, Lu Y, Jones KD, Swanson MG, Chang SD, Carrol PR, Hricak H (2002) Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 223:91–97

    PubMed  Google Scholar 

  57. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB (2002) Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 16:451–463

    Article  PubMed  Google Scholar 

  58. Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, Zaloudek CJ, Nelson SJ, Carroll PR, Kurhanewicz J (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging—clinicopathologic study. Radiology 213:473–480

    PubMed  Google Scholar 

  59. Yu KK, Scheidler J, Hricak H, Vigneron DB, Zaloudek CJ, Males RG, Nelson SJ, Carroll PR, Kurhanewicz J (1999) Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213:481–488

    CAS  PubMed  Google Scholar 

  60. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll PR, Nelson SJ (1996) Three-dimensional H-1 MR spectroscopic imaging in situ human prostate with high (0.24–0.7 cm3) spatial resolution. Radiology 198:795–805

    CAS  PubMed  Google Scholar 

  61. Jager GJ, Ruijter ET, van de Kaa CA, de la Rosette JJ, Oosterhof GO, Thornbury JR, Ruijs SH, Barentsz JO (1997) Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 203:645–652

    CAS  PubMed  Google Scholar 

  62. Ogura K, Maekawa S, Okubo K, Aoki Y, Okada T, Oda K, Watanabe Y, Tsukayama C, Arai Y (2001) Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. Urology 57:721–726

    Article  CAS  PubMed  Google Scholar 

  63. Padhani AR, Gapinski CJ, Macvicar DA, Parker GJ, Suckling J, Revell PB, Leach MO, Dearnaley DP, Husband JE (2000) Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55:99–109

    CAS  PubMed  Google Scholar 

  64. Preziosi P, Orlachio A, Giambattista GD, Renzi PD, Bortolotti L, Fabiano A, Cruciani E, Pasqualetti P (2003) Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol 13:925–930

    PubMed  Google Scholar 

  65. Rouvière O, Raudrant A, Ecochard R, Colin-Pangaud C, Pasquiou C, Bouvier R, Maréchal JM, Lyonnet D (2003) Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging. Eur Radiol 13:931–942

    PubMed  Google Scholar 

  66. Schlemmer HP, Merkle J, Grobholz R, Jaeger T, Michel MS, Werner A, Rabe J, van Kaick G (2004) Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? Eur Radiol. 14:309–317

    Google Scholar 

  67. Huisman HJ, Engelbrecht MR, Barentsz JO (2001) Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate. J Magn Reson Imaging 13:607–614

    Article  CAS  PubMed  Google Scholar 

  68. Helbich TH, Gossman A, Mareski PA, Raduchel B, Roberts TP, Shames DM, Muhler M, Turetschek K, Brasch RC (2000) A new polysaccharide macromolecular contrast agent for MR imaging: biodistribution and imaging characteristics. J Magn Reson Imaging 11:694–701

    CAS  PubMed  Google Scholar 

  69. Ophir J, Cespedes I, Ponekanti H, Yazdi Y, Li X (1991) Elastography: a quantitative method for imaging the elasticity of biologic tissues. Ultrason Imaging 13:111–134

    CAS  PubMed  Google Scholar 

  70. Muthupillai R, Lomas DJ, Rossman PJ, Greanleaf JF, Manduca A, Ehman RL (1995) Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 26:1854–1857

    Google Scholar 

  71. Purohit RS, Shinohara K, Meng MV, Carroll PR (2003) Imaging clinically localized prostate cancer. Urol Clin North Am 30:279–293

    PubMed  Google Scholar 

  72. Cochlin DL, Ganatra RH, Griffiths DF (2002) Elastography in the detection of prostatic cancer. Clin Radiol 57:1014–1020

    Article  PubMed  Google Scholar 

  73. Sommerfeld HJ, Garcia-Schurmann JM, Schewe J, Kuhne K, Cubick F, Berges RR, Lorenz A, Pesavento A, Scheipers S, Ermert H, Pannek J, Philippou S, Senge T (2003) Prostate cancer diagnosis using ultrasound elastography. Introduction of a novel technique and first clinical results. Urologe A 42:941–945

    Article  PubMed  Google Scholar 

  74. Manduca A, Oliphant TE, Dresner MA, Mahowald JL, Kruse SA, Amromin E, Felmlee JP, Greenleaf JF, Ehman RL (2001) Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal 5:237–254

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology, University Hospital Tuebingen, Hoppe-Seyler-Strasse 3, 72076, Tuebingen, Germany

    Heinz-Peter Schlemmer

  2. Department of Urology, Eberhard-Karls University, Tuebingen, Germany

    Stefan Corvin

Authors
  1. Heinz-Peter Schlemmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefan Corvin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heinz-Peter Schlemmer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schlemmer, HP., Corvin, S. Methods for volume assessment of prostate cancer. Eur Radiol 14, 597–606 (2004). https://doi.org/10.1007/s00330-004-2233-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-004-2233-4

Keywords

Search

Navigation